Brain Organoid Culture Process

Automating the brain organoid culture process

Dr. Sandra Grund-Gröschke is a biochemist with a PhD in molecular biology from the University of Salzburg. She has worked in both academic and industry settings. Her experience spans mouse model research in skin cancer and immunotherapy for cancer patients. Today, she works at Molecular Devices, helping scientists automate complex cell culture processes like culturing brain organoids.
Sandra Grund-Gröschke - PhD in Molecular Biology from the University of Salzburg

Inquiring minds want to know:

Why are scientists using brain organoids for their neuroscience research?

Scientists are increasingly using brain organoids in neuroscience research because they provide a more accurate model of the human brain than traditional two-dimensional cell cultures. Derived from induced pluripotent stem cells (iPSCs), brain organoids are three-dimensional, miniaturized models that mimic both the architecture and functionality of human brain tissue.

Unlike flat 2D cultures that typically contain a single cell type, brain organoid models include multiple interacting cell types—such as neurons, astrocytes, and other supporting cells—that self-organize into structures resembling real brain regions. This complexity allows researchers to study cortical layering, regional specification, and neural activity in a way that closely mirrors actual human brain development.

“Importantly, brain organoids enable researchers to model diseases and disorders that are exceptionally difficult to replicate accurately in animals. The human cortex, for example, is far larger and more complex than that of a mouse, meaning that animal models can only provide limited insight.”

Brain organoids replicate the structural and functional complexity of human brain tissue

Brain organoids replicate the structural and functional complexity of human brain tissue, making them superior to traditional 2D cultures.

Brain organoids are also opening doors to personalized medicine and a deeper understanding of the role the genome may play in disorders such as epilepsy. By generating organoids from the stem cells of patients with such disorders, there is now the potential to understand in far more detail what causes these conditions and how they might be treated.

Because of these advantages, brain organoids are now being used to:

  • Model neurological diseases such as Alzheimer’s, Parkinson’s, and epilepsy
  • Study human brain development at early stages
  • Test potential therapeutic strategies in a controlled laboratory setting


By combining cellular diversity, structural organization, and functional activity, brain organoids are revolutionizing neuroscience research and offering insights that were not possible with simpler models.

Can brain organoid culture be automated?

Automating brain organoid culture addresses one of neuroscience research’s biggest challenges: complexity. Unlike manual methods that are time-consuming, variable, and prone to contamination, automation ensures consistent feeding, monitoring, and handling. This improves reproducibility, reduces errors, and frees researchers to focus on discovery instead of routine maintenance.

Challenges of Brain Organoid Culture: Why Manual Methods Fall Short

Despite their promise, brain organoids are notoriously difficult to culture manually, even compared to other organoids. Brain organoids require constant motion and regular feeding to develop properly.

Some of the challenges Dr. Sandra has observed include:

Automated Brain Organoid Culture: A Scalable Solution for Neuroscience Research

“In the early stages of development, brain organoids must be monitored daily to confirm key morphological milestones, such as the formation of characteristic buds of cerebral organoids around day ten. Missing these signs can result in weeks of wasted effort.”

Here’s how automation helps overcome the biggest challenges in brain cell culture:

Why Brain Organoid Automation Is Complex: Motion and Culture Requirements

So why has brain organoid automation not become mainstream until now? The answer lies in the unique and complex demands of brain organoid culture.

“Most automation platforms are designed for static cultures and cannot accommodate the dynamic conditions required for brain organoids.”

The need for constant motion

First, brain organoids must be kept in continuous motion. This ensures that nutrients and oxygen are evenly distributed throughout the culture for optimal nutrient availability close to the organoid, which is key to optimal organoid maturation. Neurons are metabolically active, and consume large amounts of nutrients during development. Without movement, necrotic cores inside the organoids can form, lead to cell death and compromised functionality.

Additionally, media agitation keeps organoids suspended and evenly distributed, preventing them from settling at the bottom of the plate—an important step for maintaining healthy growth and consistent quality.

Traditionally, orbital shakers have been used to maintain this motion. However, integrating them into automated systems has been a challenge.

An exceptionally complex culture process

The brain organoid culture workflow is notoriously complex. It involves frequent media exchanges, switching between plate formats, and timed delivery of growth factors. Other steps - such as maintaining sterility over months of culture, and capturing imaging data at defined intervals - require equally careful handling.

"These challenges don’t just slow experiments — they also limit scalability, making it difficult for labs to expand the number of organoids, maintain reproducibility across experiments, or share protocols more broadly"

Introducing the latest upgrade to the CellXpress.ai Automated Cell Culture System

An Automated brain organoid culture and analysis workflow

An automated brain organoid culture and analysis workflow – starting from iPSCs and ending in morphological and functional analysis.

The CellXpress.ai® Automated Cell Culture System is designed to overcome all of these challenges. It combines a liquid handler, imager, and incubator into a single, unified platform, all controlled by one intuitive software interface. This eliminates the need for multiple programs and ensures seamless coordination between devices. It also makes the system significantly more accessible to scientists, particularly those lacking coding experience.

The addition of a new rocking incubator in this system now enables scientists to automate the culture of brain organoids, as demonstrated in this study, The CellXpress.ai Automated Cell Culture System for automated, robust brain organoid generation.

New rocking incubator for optimal brain organoid maturation

The CellXpress.ai system's new rocking incubator is a breakthrough for brain organoid culture. It supports dynamic motion within the incubator, allowing organoids to remain in constant movement throughout their development. The incubator can hold up to six racks, with a mix-and-match configuration that supports both static and rocking conditions. This means researchers can culture stem cells and brain organoids in the same incubator, with only the racks that require motion being rocked. Comparative studies have shown that organoids grown on a rocker are functionally and morphologically identical to those grown using an orbital shaker.

A rocking incubator within CellXpress.ai system enables culture of brain organoids
A rocking incubator within the CellXpress.ai system enables the long-term culture of brain organoids.

Accelerating Neurodegenerative Disease Research

Previously, manually maintaining just 10 brain organoid plates, including daily feeding and imaging, required nearly 27 hours of hands-on time each week. Now, by automating the process, that same manual work is reduced to just a few hours.

“By automating brain organoid culture, users can now generate reproducible brain organoids while significantly reducing their manual workload by up to 90%.”

Beyond time savings, the CellXpress.ai system brings scientific precision to brain organoid development. It automates feeding and imaging on a fixed schedule - including weekends - ensuring consistent treatment across samples and minimizing variability. The system also reduces cross-contamination risks, maintains optimal media conditions at 37°C, and captures full-well imaging with advanced feature analysis. Researchers can now track the entire cell journey over time, unlocking deeper insights while preserving culture integrity.

Find out more about the CellXpress.ai Automated Cell Culture System here.

Recent posts